XML 43 R25.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Financial expenses, net | 12 Months Ended
--- | ---
Dec. 31, 2021
Financial expenses, net | NOTE 17—Financial expenses, net:
|  | Year ended December, 31 |
|  | 2021 |  |  | 2020 |  |  | 2019 |
|  | (U.S. $ in millions) |
Interest expenses and other bank charges |  |  | 891 |  |  |  | 901 |  |  |  | 822 |
(Income) loss from investments (1) |  |  | 90 |  |  |  | (104 | ) |  |  | (41 | )
Foreign exchange (gains) losses, net |  |  | 7 |  |  |  | (26 | ) |  |  | (15 | )
Other, net (2) |  |  | 71 |  |  |  | 62 |  |  |  | 55 |
Total finance expense, net |  | $ | 1,058 |  |  | $ | 834 |  |  | $ | 822 |
(1) | (Income) loss from investments in 2021 and 2020 comprised mainly of revaluation gains and loss of Teva’s investment in American Well Corporation (“American Well”). See note 20.
(2) | Amortization of issuance costs and terminated derivative instruments.

X
- Definition Financial Expenses Net [Text Block] + References No definition available. + Details
Name: | teva_FinancialExpensesNetTextBlock
Namespace Prefix: | teva_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration